TY - GEN 
AU - Galvis C.E.
AU - Troncoso G.
AU - Agudelo-Pérez S.
AU - Romero H.
AU - Buitrago A.P.
AU - Gutiérrez I.F.
PY - 2024
UR - http://hdl.handle.net/10818/63308
AB - Respiratory syncytial virus infection constitutes a significant burden of morbidity and mortality in high-risk children. Palivizumab prophylaxis is considered the primary strategy to prevent severe infections in this population. To establish...
LA - eng
PB - Infectio
KW - Down syndrome
KW - Palivizumab
KW - Preterm neonate
TI - Expert Consensus on Recommendations for Palivizumab Prophylaxis for Respiratory Syncytial Virus in Children in Colombia
DO - 10.22354/24223794.1189
ER -